Literature DB >> 27613540

The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions.

Philip Z Svigals1, Amit Chopra2, James G Ravenel3, Paul J Nietert4, John T Huggins1.   

Abstract

We compared the accuracy of pleural ultrasound versus chest CT versus chest radiograph (CXR) to determine radiographic complexity in predicting a complicated parapneumonic effusion (CPPE) defined by pleural fluid analysis. 66 patients with parapneumonic effusions were identified with complete data. Pleural ultrasound had a sensitivity of 69.2% (95% CI 48.2% to 85.7%) and specificity of 90.0% (95% CI 76.3% to 97.2%). Chest CT had a sensitivity of 76.9% (95% CI 56.3% to 91.0%) and specificity of 65.0% (95% CI 48.3% to 79.4%). CXR had a sensitivity of 61.5% (95% CI 40.6% to 79.8%) and specificity of 60.0% (95% CI 43.3% to 75.1%). Pleural ultrasound appears to be a superior modality to rule in a CPPE when compared with chest CT and CXR. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Imaging/CT MRI etc; Pleural Disease; Pneumonia

Mesh:

Year:  2016        PMID: 27613540      PMCID: PMC5563972          DOI: 10.1136/thoraxjnl-2016-208904

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

Review 1.  Treatment of complicated pleural effusions in 2013.

Authors:  Rahul Bhatnagar; Nick A Maskell
Journal:  Clin Chest Med       Date:  2013-01-17       Impact factor: 2.878

2.  Computed tomography and ultrasound in parapneumonic effusions and empyema.

Authors:  S E Kearney; C W Davies; R J Davies; F V Gleeson
Journal:  Clin Radiol       Date:  2000-07       Impact factor: 2.350

Review 3.  Imaging the pleura: sonography, CT, and MR imaging.

Authors:  T C McLoud; C D Flower
Journal:  AJR Am J Roentgenol       Date:  1991-06       Impact factor: 3.959

Review 4.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

5.  Comparison of ultrasound and CT in the evaluation of pneumonia complicated by parapneumonic effusion in children.

Authors:  Jessica Kurian; Terry L Levin; Bokyung K Han; Benjamin H Taragin; Samuel Weinstein
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

  5 in total
  6 in total

Review 1.  Interpreting pleural fluid results .

Authors:  Rachel M Mercer; John P Corcoran; Jose M Porcel; Najib M Rahman; Ioannis Psallidas
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

2.  A 40-Year-Old Man With Respiratory Failure and Sepsis.

Authors:  Maaz Sheikh; Asem Qadeer; Sahar Ahmad; Kinner Patel
Journal:  Chest       Date:  2022-04       Impact factor: 9.410

3.  Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion.

Authors:  Charles A James; P Spencer Lewis; Mary B Moore; Kevin Wong; Emily K Rader; Paula K Roberson; Nancy A Ghaleb; Hanna K Jensen; Amir H Pezeshkmehr; Michael H Stroud; Daniel J Ashton
Journal:  Pediatr Radiol       Date:  2022-04-22

Review 4.  Point-of-Care Thoracic Ultrasonography in Patients With Cirrhosis and Liver Failure.

Authors:  Kamal Kajal; Madhumita Premkumar; Sreedhara B Chaluvashetty; Harish Bhujade; Anand V Kulkarni
Journal:  Cureus       Date:  2021-06-10

Review 5.  Evaluation and management of pleural sepsis.

Authors:  Justin K Lui; Ehab Billatos; Frank Schembri
Journal:  Respir Med       Date:  2021-07-28       Impact factor: 4.582

6.  Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.

Authors:  David T Arnold; Fergus W Hamilton; Karen T Elvers; Stuart W Frankland; Natalie Zahan-Evans; Sonia Patole; Andrew Medford; Rahul Bhatnagar; Nicholas A Maskell
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.